Ravi S Harapanhalli from 8310 Larkmeade Ter, Rockville, MD 20854, age 66, Phone: 2404048668

Resumes

Senior Vice President Global Regulatory Affairs

view source

Location:

Silver Spring, MD

Industry:

Pharmaceuticals

Work:

PAREXEL International since Nov 2012
Vice President
PAREXEL International - Bethesda, MD Aug 2008 - Oct 2012
Principal Consultant
FDA Aug 1997 - Jul 2008
Branch Chief

Education:

Indian Instutute of Technology, Bombay 2000 - 2006
MS and Ph.D., Medicinal and Pharmaceutical Chemistry University of Medicine and Dentistry of New Jersey 1989 - 2004
Postdoctoral Fellowship, Radiopharmaceuticals

Skills:

Regulatory Affairs
Fda
Pharmaceutical Industry
Regulatory Submissions
Pharmaceutics
Drug Development
Biotechnology
Gmp
Life Sciences
Validation
Clinical Development
Glp
Biosimilars
Clinical Trials
Product Development
Organic Chemistry
Technology Transfer
Ind
Oncology
Fda Gmp
Radiopharmaceuticals
Sop
Biopharmaceuticals
Quality By Design
Quality Assurance
Analytical Chemistry
R&D
Radiochemistry
Leadership
Gcp
Gmps
Clinical Research
Process Validation
Change Control
Medical Devices
Capa
Quality System
Regulatory Compliance
Process Simulation
Hplc
Cro
Sop Development
Commercialization
Drug Delivery
Pharmacology
Toxicology
Pma
Maa
Drug Discovery
Science

Interests:

Social Services
Children
Education
Environment
Science and Technology
Health

Languages:

Hindi
Kannada
Marathi

Certifications:

Diplomat of the American Board of Science In Nuclear Medicine (Absnm)
American Board of Science In Nuclear Medicine

Principal Consultant At Parexel Consulting

view source

Position:

Principal Consultant at PAREXEL Consulting

Location:

Washington D.C. Metro Area

Industry:

Pharmaceuticals

Work:

PAREXEL Consulting
Principal Consultant

Us Patents

Compounds For Tumor Diagnosis And Therapy
view source
US Patent:

8168159, May 1, 2012
Filed:

Apr 3, 2009
Appl. No.:

12/418563
Inventors:

Amin I. Kassis - Chestnut Hill MA, US
Ravi S. Harapanhalli - Silver Spring MD, US
Assignee:

President and Fellows of Harvard College - Cambridge MA
International Classification:

A61K 51/00
US Classification:

424 173, 424 177, 435195, 435200, 435212, 435215, 435219, 514 25, 514 75, 514 86, 514 92
Abstract:

The present invention discloses a method for the enzyme-mediated, site-specific, in-vivo precipitation of a water soluble molecule in an animal. The enzyme is either unique to tumor cells, or is produced within a specific site (e. g. , tumor) at concentrations that are higher than that in normal tissues. Alternatively, the enzyme is conjugated to a targeting moiety such as an antibody or a receptor-binding molecule.

Methods For Tumor Diagnosis And Therapy
view source
US Patent:

8603437, Dec 10, 2013
Filed:

Apr 30, 2012
Appl. No.:

13/459698
Inventors:

Amin I. Kassis - Chestnut Hill MA, US
Ravi S. Harapanhalli - Silver Spring MD, US
Assignee:

President and Fellows of Harvard College - Cambridge MA
International Classification:

A61K 51/00
A01N 43/04
US Classification:

424 173, 424 177, 435195, 435200, 435212, 435215, 435219, 514 25, 514 75, 514 86, 514 92
Abstract:

The present invention discloses a method for the enzyme-mediated, site-specific, in-vivo precipitation of a water soluble molecule in an animal. The enzyme is either unique to tumor cells, or is produced within a specific site (e. g. , tumor) at concentrations that are higher than that in normal tissues. Alternatively, the enzyme is conjugated to a targeting moiety such as an antibody or a receptor-binding molecule.

Methods For Tumor Diagnosis And Therapy
view source
US Patent:

20030021791, Jan 30, 2003
Filed:

Apr 20, 2001
Appl. No.:

09/839779
Inventors:

Amin Kassis - Chestnut Hill MA, US
Ravi Harapanhalli - Silver Spring MD, US
International Classification:

A61K051/06
A61K039/395
US Classification:

424/178100, 424/001110, 424/001730
Abstract:

The present invention discloses a method for the enzyme-mediated, site-specific, in-vivo precipitation of a water soluble molecule in an animal. The enzyme is either unique to tumor cells, or is produced within a specific site (e.g., tumor) at concentrations that are higher than that in normal tissues. Alternatively, the enzyme is conjugated to a targeting moiety such as an antibody or a receptor-binding molecule.

Methods For Tumor Diagnosis And Therapy
view source
US Patent:

20160158390, Jun 9, 2016
Filed:

Oct 9, 2015
Appl. No.:

14/879809
Inventors:

- Cambridge MA, US
Ravi S. Harapanhalli - Potomac MD, US
International Classification:

A61K 51/04
C07F 9/6512
Abstract:

The present invention discloses a method for the enzyme-mediated, site-specific, in-vivo precipitation of a water soluble molecule in an animal. The enzyme is either unique to tumor cells, or is produced within a specific site (e.g., tumor) at concentrations that are higher than that in normal tissues. Alternatively, the enzyme is conjugated to a targeting moiety such as an antibody or a receptor-binding molecule.

Methods For Tumor Diagnosis And Therapy
view source
US Patent:

20140178298, Jun 26, 2014
Filed:

Dec 9, 2013
Appl. No.:

14/100658
Inventors:

- Cambridge MA, US
Ravi S. Harapanhalli - Silver Spring MD, US
Assignee:

PRESIDENT AND FELLOWS OF HARVARD COLLEGE - Cambridge MA
International Classification:

A61K 51/04
US Classification:

424 149, 424 185, 424 165, 424 177, 424 173, 424 169
Abstract:

The present invention discloses a method for the enzyme-mediated, site-specific, in-vivo precipitation of a water soluble molecule in an animal. The enzyme is either unique to tumor cells, or is produced within a specific site (e.g., tumor) at concentrations that are higher than that in normal tissues. Alternatively, the enzyme is conjugated to a targeting moiety such as an antibody or a receptor-binding molecule.